Skip to Content

Updated Real-World Data Confirm the Effectiveness of Avelumab in First-Line Maintenance Treatment of Advanced Urothelial Carcinoma

Philippe Barthélémy discusses in this MEDtalk from ESMO 2024 the updated results from the AVENANCE trial. They confirm the effectiveness of avelumab first line maintenance in a real-world population.

Philippe Barthélémy

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top